Literature DB >> 31812758

MicroRNA and retinoic acid.

Reza Gholikhani-Darbroud1.   

Abstract

BACKGROUND AND
OBJECTIVE: Retinoic acid is a metabolite of vitamin A that is necessary to maintain health in human and most of the other vertebrates. MicroRNAs (miR or miRNAs) are small, non-coding RNA particles that diminish mRNA translation of various genes and so can regulate critical cell processes including cell death, proliferation, development, etc. The aim of this review is to study interrelations between retinoic acid with miRNAs.
METHODS: We reviewed and summarized all published articles in PubMed, Europe PMC, and Embase databases with any relationship between retinoic acid and miRNAs from Jun 2003 to Dec 2018 that includes 126 articles.
RESULTS: Results showed direct and indirect relationships between retinoic acid and miRNAs in various levels including effects of retinoic acid on expression of various miRNAs and miRNA-biogenesis enzymes, and effect of miRNAs on metabolism of retinoic acid. DISCUTION AND
CONCLUSION: This review indicates that retinoic acid has inter-correlations with various miRNA members and their metabolism in health and disease may require implications of the other.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inter-correlation; Retinoic acid; miRNA

Year:  2019        PMID: 31812758     DOI: 10.1016/j.cca.2019.12.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment.

Authors:  Carlos Garcia-Padilla; Virginio Garcia-Lopez; Amelia Aranega; Diego Franco; Virginio Garcia-Martinez; Carmen Lopez-Sanchez
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

2.  Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes.

Authors:  Katerina Grafanaki; Ilias Skeparnias; Christos K Kontos; Dimitrios Anastasakis; Aigli Korfiati; George Kyriakopoulos; Konstantinos Theofilatos; Seferina Mavroudi; George Magoulas; Dionissios Papaioannou; Andreas Scorilas; Constantinos Stathopoulos; Denis Drainas
Journal:  Pharmacogenomics J       Date:  2021-06-18       Impact factor: 3.550

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.